Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Bookman

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|August 15, 2006
Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxelRobert F Ozols, Michael A Bookman, Andreas du Bois, et al.
Obstetrics and Gynecology|August 24, 2013
Survival in women with grade 1 serous ovarian carcinomaAmanda Nickles Fader, James Java, Stefanie Ueda, et al.
Gynecologic Oncology|August 3, 2013
Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancerRobert A Burger, Mark F Brady, Joon Rhee, et al.
Journal of the National Cancer Institute|October 16, 2003
Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centersStephen B Edge, Joyce C Niland, Michael A Bookman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Reply to G.D. Aletti et alNeil Horowitz, Austin Miller, Bunja Rungruang, et al.
Gynecologic Oncology|July 24, 2019
Joint ENGOT and GOG Foundation requirements for trials with industry partnersIgnace Vergote, Robert L Coleman, Sandro Pignata, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 20, 2019
Joint ENGOT and GOG Foundation requirements for trials with industry partnersIgnace Vergote, Robert L Coleman, Sandro Pignata, et al.
Gynecologic Oncology|February 14, 2022
Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective studyJunsik Park, Se Ik Kim, Soo Young Jeong, et al.
Cancer Cell|January 30, 2004
Focus on epithelial ovarian cancerRobert F Ozols, Michael A Bookman, Denise C Connolly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network CentersThomas A Buchholz, Richard L Theriault, Joyce C Niland, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|August 15, 2006
Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxelRobert F Ozols, Michael A Bookman, Andreas du Bois, et al.
Obstetrics and Gynecology|August 24, 2013
Survival in women with grade 1 serous ovarian carcinomaAmanda Nickles Fader, James Java, Stefanie Ueda, et al.
Gynecologic Oncology|August 3, 2013
Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancerRobert A Burger, Mark F Brady, Joon Rhee, et al.
Journal of the National Cancer Institute|October 16, 2003
Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centersStephen B Edge, Joyce C Niland, Michael A Bookman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Reply to G.D. Aletti et alNeil Horowitz, Austin Miller, Bunja Rungruang, et al.
Gynecologic Oncology|July 24, 2019
Joint ENGOT and GOG Foundation requirements for trials with industry partnersIgnace Vergote, Robert L Coleman, Sandro Pignata, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 20, 2019
Joint ENGOT and GOG Foundation requirements for trials with industry partnersIgnace Vergote, Robert L Coleman, Sandro Pignata, et al.
Gynecologic Oncology|February 14, 2022
Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective studyJunsik Park, Se Ik Kim, Soo Young Jeong, et al.
Cancer Cell|January 30, 2004
Focus on epithelial ovarian cancerRobert F Ozols, Michael A Bookman, Denise C Connolly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network CentersThomas A Buchholz, Richard L Theriault, Joyce C Niland, et al.
Pageof 11